Roy R Gerona
Biographic Data
| ID | 10447595 |
|---|---|
| NAME | Roy R Gerona |
| GIVEN NAMES | Roy R |
| FAMILY NAME | Gerona |
| SIGNATURE | GERONA R R |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-Butica, MMB-4CN-Butinaca, MDMB-4F-Butica, MDMB-4F-Butinaca and their analogs
Synthetic cannabinoid receptor agonists (SCRAs) continue to make up a significant portion new psychoactive substances (NPS) detected and seized worldwide. Due to their often potent activation of central cannabinoid receptors in vivo , use of SCRAs can result in severe intoxication, in addition to other adverse health effects. Recent detections of AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA and MDMB-4F-BUTINACA mark a continuation in the appea…
A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction
This case highlights the polypharmacy which may exist among users of psychoactive illicit substances and demonstrates that concurrent use of MDMA and 3,4-DMA may predispose patients to severe toxicity. Toxicologists and other healthcare providers should be aware of this potential toxicity
No prominent works on this page.
A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction
This case highlights the polypharmacy which may exist among users of psychoactive illicit substances and demonstrates that concurrent use of MDMA and 3,4-DMA may predispose patients to severe toxicity. Toxicologists and other healthcare providers should be aware of this potential toxicity
Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-Butica, MMB-4CN-Butinaca, MDMB-4F-Butica, MDMB-4F-Butinaca and their analogs
Synthetic cannabinoid receptor agonists (SCRAs) continue to make up a significant portion new psychoactive substances (NPS) detected and seized worldwide. Due to their often potent activation of central cannabinoid receptors in vivo , use of SCRAs can result in severe intoxication, in addition to other adverse health effects. Recent detections of AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA and MDMB-4F-BUTINACA mark a continuation in the appea…
Cannabis and Cannabinoid Research (2 works) · Chemistry (2 works) · Forensic Toxicology and Drug Analysis (2 works) · Medicine (2 works) · Pharmacology (2 works) · Psychedelics and Drug Studies (2 works) · Agonist (1 work) · Anesthesia (1 work) · Biochemistry (1 work) · Biology (1 work)